Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 500-213-3 | CAS number: 68439-50-9 1 - 2.5 moles ethoxylated
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitisation (in vivo, GPMT, OECD 406): not sensitising
Conclusion based on data obtained with alcohols, C12-14, ethoxylated (CAS No. 68439-50-9, EC No. 500-213-3) and considering all available data on skin sensitisation in the Alcohol Ethoxylates (AE) category in a Weight-of-Evidence approach.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 16 Sep - 27 Oct 1996
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- adopted in 1992
- Deviations:
- yes
- Remarks:
- 10 test and 5 control animals per group were used instead of 20 test and 10 control animals. Since there is a second test on skin sensitiation in guinea pigs available, no additional testing was performed in the present study.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- The Department of Health of the Government of the United Kingdom
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Test was done before LLNA as first-choice method for in-vivo testing was set into force.
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: David Hall Limited, Staffordshire, United Kingdom
- Age at study initiation: 12 weeks
- Weight at study initiation: 329 - 427g
- Housing: singly or in pairs in solid-floor polypropylene cages furnished with woodflakes
- Diet: Guinea Pig FD1 Diet (Special Diet Services Limited, Witham, Essex, United Kingdom), ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18-22
- Humidity (%): 47-68
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12 - Route:
- intradermal and epicutaneous
- Vehicle:
- arachis oil
- Concentration / amount:
- Intradermal Induction: 1%
Topical Induction: 100% - Day(s)/duration:
- epicutaneous induction: 48 h
- Adequacy of induction:
- other: induction doses based on dose-range finding test using concentrations of 1 and 5% for dermal injection and 25, 50, 75 and 100% for epicutaneous induction
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- arachis oil
- Concentration / amount:
- Topical Challenge: 25 and 50%
- Day(s)/duration:
- 24 h
- Adequacy of challenge:
- other: dose levels for topical challenge were selected based on the results of a dose-range finding test; the highest concentration was the highest non-irritant concentration
- No. of animals per dose:
- 10 (in test group), 5 (control)
- Details on study design:
- RANGE FINDING TESTS:
Two guinea pigs were dermally injected with test item concentrations of 1 and 5%. The animal induced with the 1% formulation showed erythema of grade 3 at the 24, 48 and 72 h reading and erythema of grade 2 at the 7 day reading. The animal induced with the 5% formulation showed erythema of grade 3-4 and green necrosis 24 h after induction and erythema of grade 4 with green necrosis findings and eschar formation at the 48 h, 72 h and 7 day reading. Thus, the 1% formulation was chosen for intradermal induction.
In addition, two animals were topically treated with 25, 50, 75 and 100% concentrations for 48 h. One hour after induction, both animals showed erythema of grade 2-3 at all concentration levels. Edema of grade 2 was observed for both animals at 100% and for one animal at 75 and 50%. Edema of grade 1 was noted in one animal at 25% and at 50 and 75% in the second animal. At the 24 h reading, erythema persisted in both animals at the 75% (score 1) and 100% formulation (score 2) and in one animal at the 50% formulation (score 1). One of the animals shiwed edema formation (grade 1) at 100 and 50%, whereas no edema was observed in the second animal.
At the 48 h reading, both animals showed erythema of grade 2 at the 100% formulation test site and erythema of grade 1 at the 75% formulationt test site. In one of the animals, edema was observed (grade 1) at the 100% formulation test site.
Two additional animals were used for a sighting test on topical challenge. One hour after challenge, erythema of grade 2 was noted in both animals at 100 and 75% and erythema of grade 1 was observed at 50 and 25% in both animals. Edema of gradde 1 was noted at 100% in both animals and at 50% in one of the guinea pigs. At the 24 h reading, both animals showed erythema of grade 1 when treated at 50 and 100%. Erythma of score 1 at challenge wirh 100% persisted in one of the animals up to the 48 h time point. At the 24 and 48 h reading, no finding of edema was observed in any animal.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous, respectively)
- Exposure period: single injection (intradermal) and 48 h (epicutaneous)
- Test groups:
Intradermal (3 pairs of injections): 0.1 mL each
Injection 1: 1:1 mixture complete Freund's adjuvant (FCA) and distilled water
Injection 2: 1% test substance in arachis oil BP
Injection 3: 1% test substance in a 1:1 mixture of complete Freund's adjuvant (FCA) and distilled water
Epicutaneous: filter paper patch saturated with undiluted test material
- Control group:
Intradermal (3 pairs of injections):
Injection 1: 1:1 mixture complete Freund's adjuvant (FCA) and distilled water
Injection 2: 100% arachis oil BP
Injection 3: a 50% formulation of arachis oil BP in a 1:1 mixture of complete Freund's adjuvant (FCA) and distilled water
Epicutaneous: filter paper patch saturated with arachis oil BP
- Site: shoulder region
- Frequency of applications: topical induction was performed one week after the intradermal induction
- Duration: 7 days
- Concentrations: intradermal 1%, epicutaneous 100%
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 3 weeks after intradermal induction (study Day 21)
- Exposure period: 24 h
- Test groups: test substance and vehicle
- Control group: test substance and vehicle
- Site: left flank (test item) and right flank (vehicle)
- Concentrations: 25 and 50%
- Evaluation (hr after challenge): 48 and 72 h (24 and 48 h after dressing removal) - Challenge controls:
- The control group is actually a challenge control
- Positive control substance(s):
- yes
- Remarks:
- Historical data on ethyl-4-aminobenzoate, 2,4-dinitrochlorobenzene, neomycin sulphate and 2-mercaptobenzothiazole were provided.
- Positive control results:
- Historical control data on several positive control chemicals were provided. Challenge with 2-mercaptobenzothiazole (intrademally induced with 10% in arachis oil, topically induced with 50% in acetone and topically challenged with 25 and 50% in acetone : PEG 400 in a 70:30 ratio), exhibited dermal alterations in 70% of the test animals, thus meeting the reliability criteria for the GPMT test (≥ 15% positive reactions).
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- intradermal induction: 1%; epicutaneous induction: 100%; epicutaneous challenge: 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- intradermal induction: 1%; epicutaneous induction: 100%; epicutaneous challenge: 25%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- challenge: 25%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- challenge: 25%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- intradermal induction: 1%; epicutaneous induction: 100%; epicutaneous challenge: 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- intradermal induction: 1%; epicutaneous induction: 100%; epicutaneous challenge: 50%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- challenge: 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- challenge: 50%
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Group:
- positive control
- Dose level:
- intradermal induction: 10%; epicutaneous induction: 50%; epicutaneous challenge: 25 and 50%
- Remarks on result:
- other: Historical positive control data provided in study report
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008.
- Executive summary:
A study was performed to assess the contact sensitisation potencial of the test material in the albino guinea pig. Ten test and five control animals were used for the main study. Based on the results of sighting test, the concentration of the test material for the induction and challenge phases were selected as follows:
Intradermal Induction: 1% w/v in arachis oil BP
Topical Induction: undiluted as supplied
Topical Challenge: 50% and 25% v/v in arachis BP
The test material produced a 0% (0/10) sensitisation rate and was classified as a NON-SENSITISER to guinea pig skin. The test material did not meet the criteria for classification as a sensitiser according to EU labelling regulations. No risk phrase is required.
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- 20 Sep- 21 Oct 1988
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Version / remarks:
- adopted in 1992
- Deviations:
- yes
- Remarks:
- no reliablity check reported; control animals were not handled according to guideline (no application of vehicle) during 2nd induction.
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- GLP compliance:
- yes
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Test was done before LLNA as first-choice method for in-vivo testing was set into force.
- Species:
- guinea pig
- Strain:
- other: Pirbright white
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Interfauna, Tuttlingen, Germany
- Females nulliparous and non-pregnant: yes
- Weight at study initiation: 314.6 and 323.1 g (main study) and 397.4 and 400.3 g (sighting study)
- Housing: In groups of 3 in Makrolon type IV cages
- Diet: Altromin Haltungsdiät 3032 (Altromin GmbH, Lage, Germany), ad libitum
- Water: tap water, ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 50 - 60
- Photoperiod (hrs dark / hrs light): 12/12 - Route:
- intradermal and epicutaneous
- Vehicle:
- water
- Concentration / amount:
- Intradermal induction: 0.1%
Epicutaneous induction: 15% - Day(s)/duration:
- epicutaneous induction: 48 h
- Adequacy of induction:
- other: induction dose levels based on a range-finding test performed, in which intradermal injection at 0.1% caused sufficient irritation; topical induction at 15% caused slight to well-defined skin reactions
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- water
- Concentration / amount:
- Challenge: 2.5 and 5%
- Day(s)/duration:
- 24 h
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- 20
- Details on study design:
- RANGE FINDING TESTS:
Three guinea pigs were dermally injected with test item concentrations of 0.1, 0.5, 1.0 and 2.0%. The formulation of 0.1% produced sufficient irritation in the animals, therefore 0.1% was chosen as concentration for the intradermal injection.
In addition, three animals were topically treated with 5, 10 and 15% concentrations for 48 h. The 15% caused slight to well defined skin reactions in all animals, whereas the 10% formulation caused a weak response in 2/3 animals. Thus, 15% was chosen as concentration for topical induction and 2.5 and 5% were chosen as concentrations for topical challenge.
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 2 (intradermal and epicutaneous, respectively)
- Exposure period: single injection (intradermal) and 48 h (epicutaneous)
- Test groups:
Intradermal (3 pairs of injections): 0.1 mL each
Injection 1: 1:1 mixture complete Freund's adjuvant (FCA) and physiological saline
Injection 2: 0.1% test substance in water
Injection 3: 0.2% test substance in a 1:1 mixture of complete Freund's adjuvant (FCA) and physiological saline
Epicutaneous:
- Control group:
Intradermal (3 pairs of injections):
Injection 1: 1:1 mixture complete Freund's adjuvant (FCA) and physiological saline
Injection 2: not performed as water was used as solvent
Injection 3: a 1:1 mixture of complete Freund's adjuvant (FCA) and physiological saline and water
Epicutaneous:
- Site: shoulder region
- Frequency of applications: topical induction was performed one week after the intradermal induction
- Duration: 7 days
- Concentrations: intradermal 0.1%, epicutaneous 15%
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: 14 days after intradermal induction (study Day 21)
- Exposure period: 24 h
- Test groups: test substance and vehicle
- Control group: test substance and vehicle
- Site: left flank
- Concentrations: 2.5 and 5.0%
- Evaluation (hr after challenge): 48 and 72 h (24 and 48 h after patch removal) - Challenge controls:
- The control group is actually a challenge control
- Positive control substance(s):
- no
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- challenge: 2.5%
- No. with + reactions:
- 0
- Total no. in group:
- 18
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- challenge: 2.5%
- No. with + reactions:
- 0
- Total no. in group:
- 18
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- intradermal induction: 0.1%; epicutaneous induction: 15%; epicutaneous challenge: 2.5%
- No. with + reactions:
- 0
- Total no. in group:
- 19
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- intradermal induction: 0.1%; epicutaneous induction: 15%; epicutaneous challenge: 2.5%
- No. with + reactions:
- 0
- Total no. in group:
- 19
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- challenge: 5%
- No. with + reactions:
- 4
- Total no. in group:
- 18
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- challenge: 5%
- No. with + reactions:
- 4
- Total no. in group:
- 18
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- intradermal induction: 0.1%; epicutaneous induction: 15%; epicutaneous challenge: 5%
- No. with + reactions:
- 4
- Total no. in group:
- 19
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- intradermal induction: 0.1%; epicutaneous induction: 15%; epicutaneous challenge: 5%
- No. with + reactions:
- 5
- Total no. in group:
- 19
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008.
Referenceopen allclose all
Local skin reactions:
After intradermal induction, well-defined or moderate to severe erythema was noted at the induction sites of all test group animals at the 24- and 48-h observation. Very slight erythema was noted at the intradermal induction sites of 4 control animals at the 24 and 48 h reading.
After topical induction, very slight to moderate to severe erythema with or without very slight edema was noted at the induction sites of all test group animals at the 1-h observation. Very slight to well-defined erythema with or without very slight to slight edema was noted at the induction sites of seven test group animals at the 24-h observation. Dried blood was noted at the induction sites of six test group animals at the 24 -h observation. Skin reactions prevented the accurate evaluation of erythema and edema at the induction sites of two test group animals at the 24 -h observation. No skin reactions were noted at the treatment sites of control group animals at the 1- and 24-h observations.
After
topical challenge, no skin reactions were observed in any control or
test item-treated animal at the 24 and 48 -h observation.
Table 1: Skin sensitisation results
Animals Number | skin Reactions (Hours After Removal of Dressing) |
|||||||||||
24 h | 48 h | |||||||||||
50% | 25% | 50% | 25% | |||||||||
Er | Oe | Other | Er | Oe | Other | Er | Oe | Other | Er | Oe | Other | |
1 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
2 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
3 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
4 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
5 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
6 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
7 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
8 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
9 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
10 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
Er=erythema
Oe=oedema
- = no other reactions noted
Er=erythema
Oe=oedema
- = no other reactions noted
Systemic toxicity: Not reported.
Body weight: All animals gained weight as expected.
Local skin reactions:
Intradermal injection of Freund's adjuvant (FCA) showed typical skin reactions in all animals. Injection of the test item in the absence of FCA was associated with slight to well defined skin reactions in the animals, however, the skin reactions were less severe than those caused by FCA injection or by injection of test item in the presence of FCA.
After topical induction, bloody skin reactions were noted at the test areas treated with FCA, which turned into necrotic or scab skin reactions thereafter.
after challenge, no skin reactions were noted in test item- or vehicle control-treated animals at any reading time point.
Systemic toxicity:
1/20 control animals died on study Day 14 and 1/20 control animals was not treated due to illness. 1/20 test item treated animals showed strong skin reactions in the neck area and was sacrificed for humane reasons after the topical induction.
Body weight development:
Test item-treated animals showed a reduced body weight development when compared to control animals. The finding was explained by reduced food consumption during the topical induction, which was attributed to impairment caused by the dressing.
Table 1: Body weight and body weight gain (mean ± SD) during the skin sensitisation study in guinea pigs
BW Day 0 | BW Week 1 | BW Week 3 | BWG | |
Control | 314.6 ± 33.7 | 365.4 ± 37.5 | 460.5 ± 49.1 | 147.8 ± 31.3 |
Test item | 323.1 ± 26.6 | 375.0 ± 35.7 | 458.7 ± 47.4 | 136.6 ± 30.1 |
BW: Body weight; BWG: Body weight gain |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Data on skin sensitisation are available for alcohols, C12-14, ethoxylated (CAS No. 68439-50-9, EC No. 500-213-3) as well as several member substances of the Alcohol Ethoxylates (AE) category.
Studies with alcohols, C12-14, ethoxylated
The skin sensitising potential of alcohols, C12-14, ethoxylated (CAS No. 68439-50-9, EC No. 500-213-3) was assessed in a Guinea Pig Maximisation Test (GPMT) according to OECD guideline 406 observing GLP conditions (Kao, 1996b). Ten test and five control animals (female Dunkin-Hartley guinea pigs) were used for the main study. Based on the results of sighting tests, a concentration of 1% (w/v) of the test substance in arachis oil BP for the intradermal induction was chosen. For the topical induction the test substances was used undiluted and the topical challenge was performed with 25% and 50% (v/v) in arachis oil BP. The test material was considered as a non-sensitiser to guinea pig skin.
The result of the first study is supported by another GMPT performed according to OECD guideline 406 under GLP conditions (BASF, 1988b). First the minimum irritant concentration for the induction applicaton (intracutaneous and epidermal) and the maximum non irritant concentration for the challenge applicaton were estimated in separate pre-tests. For the main test, 20 female guinea pigs (Pirbright white) each for the test and for the control group were used. The test substance was applied as an aqueous solution for the intracutaneous as well as for the epicutaneous application. 24 and 48 h after removing the patches of the challenge application (2.5% aqueous solution), the test substance caused no skin reaction on the test and on the control animals. According to these findings, the test substance is regarded as a non-sensitiser.
Studies in the AE category
Studies investigating skin sensitisation are available for the following AE substances:
CAS No.
EC No.
Substance
Study protocol
Hazard conclusion
27252-75-1
500-058-1
Octan-1-ol, ethoxylated
OECD 442E
Negative in the activation of dendritic cells
OECD 442D
Positive for keratinocyte activation
68439-50-9
500-213-3
Alcohols, C12-14, ethoxylated
OECD 406
Not sensitising
Similar OECD 406
Not sensitising
68439-49-6
939-518-5
Alcohols, C16-18 (even numbered), ethoxylated, < 2.5 EO
OECD 406
Not sensitising
66455-14-9
500-165-3
Alcohols, C12-13, ethoxylated
Similar OECD 406
Not sensitising
Evaluation of skin sensitisation as observed in studies
All available study results indicate that AE substances have no potential to induce skin sensitisation. None of the category member substances turned out to be sensitising to skin in in vivo investigations (GPMT and Buehler test design), thus demonstrating similar toxicological properties. The maximum number of positively induced animals was 5 out of a group of 19 animals in the second study performed with alcohols, C12-14, ethoxylated (CAS No. 68439-50-9, EC No. 500-213-3). No animal showed a positive response in any of the other in vivo studies. The in vitro studies with octan-1-ol, ethoxylated (CAS No. 27252-75-1, EC No. 500-058-1) resulted in an inconclusive picture. A further investigation would be needed to finally conclude on the in vitro skin sensitisation potential of the substance. However, no further testing for the substance is warranted as it is corrosive to skin. In conclusion, the inconclusive assessment for octan-1-ol, ethoxylated (CAS No. 27252-75-1, EC No. 500-058-1) is not considered to invalidate the general findings of the in vivo studies, especially as this substance exhibits corrosive properties. Based on all available data on skin sensitisation in the AE category, it is established that the AE substances are not sensitising to skin.
This evaluation is considered sufficiently conclusive for the hazard assessment and classification and labelling of the AE substances. For a detailed evaluation of the skin sensitisation potential of the substances in the AE category, please refer to the category justification attached to the category object.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The available data on skin sensitisation obtained with alcohols, C12-14, ethoxylated (CAS No. 68439-50-9, EC No. 500-213-3) and with other members of the Alcohol Ethoxylates (AE) category do not meet the criteria for classification according to the CLP Regulation (EC) No. 1272/2008 and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.